WO2022124124A1 - Chemical agent volatizer - Google Patents

Chemical agent volatizer Download PDF

Info

Publication number
WO2022124124A1
WO2022124124A1 PCT/JP2021/043708 JP2021043708W WO2022124124A1 WO 2022124124 A1 WO2022124124 A1 WO 2022124124A1 JP 2021043708 W JP2021043708 W JP 2021043708W WO 2022124124 A1 WO2022124124 A1 WO 2022124124A1
Authority
WO
WIPO (PCT)
Prior art keywords
liquid
core material
drug
absorbing core
drug container
Prior art date
Application number
PCT/JP2021/043708
Other languages
French (fr)
Japanese (ja)
Inventor
勧 小林
文沁 肖
Original Assignee
小林製薬株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 小林製薬株式会社 filed Critical 小林製薬株式会社
Publication of WO2022124124A1 publication Critical patent/WO2022124124A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01MCATCHING, TRAPPING OR SCARING OF ANIMALS; APPARATUS FOR THE DESTRUCTION OF NOXIOUS ANIMALS OR NOXIOUS PLANTS
    • A01M1/00Stationary means for catching or killing insects
    • A01M1/20Poisoning, narcotising, or burning insects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/015Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/12Apparatus, e.g. holders, therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D85/00Containers, packaging elements or packages, specially adapted for particular articles or materials

Definitions

  • a liquid absorbing core material is inserted into a drug container containing a liquid drug such as an aromatic liquid or a deodorant, and the liquid drug is sucked up by the liquid absorbing core material to create a space outside the drug container (the present disclosure). Then, it is related to the drug volatilizer that volatilizes in the "external space").
  • the drug volatilizer using the drug solution includes a drug container for accommodating the drug solution and a rod-shaped liquid absorbing core material inserted into the drug container.
  • the liquid-absorbent core material is held at the mouth of the drug container so that the lower end reaches the inner bottom surface of the drug container and a part of the upper end side protrudes upward from the drug container, and the drug solution is sucked up by capillarity and volatilized into the external space. ..
  • the height of the liquid level of the drug solution in the drug container is the upper surface of the bottom of the drug container ( In this disclosure, it is referred to as "inner bottom surface"), depending on the specifications of the liquid-absorbing core material (for example, specifications that make it difficult to absorb chemicals from the outer peripheral surface by performing a treatment to improve the strength of the outer peripheral surface).
  • the specifications of the liquid-absorbing core material for example, specifications that make it difficult to absorb chemicals from the outer peripheral surface by performing a treatment to improve the strength of the outer peripheral surface.
  • it is difficult to suck up all the chemicals in the drug container with the liquid absorbing core material and in that case, there is a problem that the chemicals cannot be used up to the end.
  • the present invention has been made focusing on the above-mentioned problems, and an object of the present invention is to provide a drug volatilizer capable of sucking up a drug solution satisfactorily with a liquid absorbing core material when the remaining amount of the drug solution in the drug container is reduced. And.
  • the present invention relates to a drug volatilizer in which a liquid absorbing core material is inserted into a drug container containing a liquid drug, and the liquid drug is sucked up by the liquid absorbing core material and volatilized in an external space.
  • the drug volatilizer of the present invention is inserted into the drug container so that the drug container containing the liquid drug and the lower end of the drug container reach the inner bottom surface of the drug container and a part of the upper end side protrudes upward from the drug container.
  • a liquid-absorbing core material that is provided with a liquid-absorbing core material that sucks up the liquid drug, and a liquid pool portion that is concavely dented at a position where the lower end of the liquid-absorbing core material reaches the inner bottom surface of the drug container. Is provided.
  • the drug volatilizer of the present invention is preferably configured such that the liquid pool portion has a size of being covered from above by the liquid absorbing core material.
  • the cross-sectional view of the liquid absorbing core material is preferably circular, the plan view of the liquid pool is circular, and the outer diameter of the liquid pool is large. It can be configured to be smaller than the inner diameter at the lower end of the liquid absorbing core material.
  • the drug volatilizer of the present invention is preferably configured such that the liquid pool portion is located at the center of the inner bottom surface of the drug container.
  • the drug volatilizer of the present invention when the remaining amount of the drug solution in the drug container is reduced, the drug solution can be satisfactorily sucked up by the liquid absorbing core material.
  • FIG. 4 is an enlarged vertical sectional view (A) and a horizontal sectional view (B) showing the bottom side of the drug container of FIG. 4. It is a top view of the state which attached the cap to the medicine container in the medicine volatilizer of this embodiment. It is a top view of the state which attached the cover to the medicine container in the medicine volatilizer of this embodiment.
  • a liquid absorbing core material is inserted into a drug container containing a liquid drug (drug solution) having volatilization property, and the drug solution is sucked up by the capillary phenomenon of the liquid absorbing core material to release the drug component of the drug solution. It is to be volatilized in the external space.
  • the chemical volatilizer of the present invention uses a fragrance liquid, a deodorant liquid, or the like as a chemical liquid in order to eliminate the discomfort caused by the odor of a space such as a room or a car, and to use a fragrance liquid or a deodorant component as a chemical liquid. It is used for the purpose of obtaining medicinal effects such as fragrance and deodorization by naturally volatilizing such substances.
  • the above-mentioned purpose of use of the drug volatilizer of the present invention is merely an example.
  • the height direction of the self-supporting drug volatilizer is the vertical direction.
  • the drug volatilizer 1 includes a drug container 2 for accommodating a drug solution and a liquid absorbing core material 3 inserted into the drug container 2. Further, the drug volatilizer 1 preferably further includes a cap 4 and a cover 5 that can be attached to and detached from the drug container 2.
  • the lower end of the liquid absorbing core material 3 reaches the upper surface of the bottom portion 62 of the drug container 2 (referred to as “inner bottom surface” in the present disclosure), and a part of the upper end side is upward from the drug container 2. It is held in the mouth 20 of the drug container 2 so as to protrude.
  • the liquid-absorbing core material 3 sucks up the chemical solution by a capillary phenomenon at a portion in contact with the chemical solution, thereby volatilizing the drug component into the external space.
  • the cap 4 is attached to the mouth portion 20 of the drug container 2 so as to cover the portion of the liquid absorbing core material 3 that protrudes upward from the drug container 2. Since the liquid-absorbent core material 3 is largely sealed by the cap 4 and shielded from the external space, the drug component of the chemical solution does not continuously volatilize from the liquid-absorbent core material 3 when the cap 4 is attached to the drug container 2. , Not released into the external space. Therefore, the cap 4 is used when the drug volatilizer 1 is not used, and is removed from the mouth 20 of the drug container 2 when used. When the cap 4 is removed from the mouth 20 of the drug container 2, the drug component of the drug solution sucked up by the liquid absorbing core material 3 is volatilized and released to the external space, and the drug volatilizer 1 exerts its medicinal effect.
  • the cover 5 is mainly used when the drug volatilizer 1 is used, and from the design viewpoint of the drug volatilizer 1, the portion of the liquid absorbing core material 3 protruding from the drug container 2 can be visually recognized from the outside. It is attached to the drug container 2 to make it difficult to do.
  • a plurality of volatilization holes 53 are formed in the cover 5, and when the cover 5 is attached to the drug container 2, the drug component of the drug solution volatilized from the liquid absorbing core material 3 passes through the respective volatilization holes 53 of the cover 5. And it is released to the external space.
  • the chemical solution has volatilization property (sustained release property), and exerts a medicinal effect by gradually volatilizing the drug component into the air by contact with air.
  • the drug solution contains a drug component.
  • the drug component include an fragrance component, a deodorant component, an insecticide component, an insect repellent component, a repellent component, an antibacterial agent component, and the like.
  • the drug solution may contain one of these drug components alone, or may contain a plurality of them in combination.
  • the drug component may be either oily or aqueous as long as it can be volatilized.
  • the viscosity of the chemical solution is not particularly limited, but is preferably 0.1 mPa ⁇ s or more and 30 mPa ⁇ s or less, more preferably 0.1 mPa ⁇ s or more and 20 mPa ⁇ s or less, and 0. It is more preferable that it is 1 mPa ⁇ s or more and 10 mPa ⁇ s or less.
  • the viscosity of the chemical solution can be measured in an environment of 25 ° C. using a vibration viscometer (VM-3OO-L manufactured by Sekonic).
  • the drug container 2 has a mouth portion 20 having both upper and lower ends open, and the liquid absorbing core material 3 is inserted into the drug container 2 from the mouth portion 20. Further, the liquid absorbing core material 3 is held in the mouth portion 20 to prevent it from coming out of the drug container 2.
  • the drug container 2 is preferably composed of a container body 6 and a tubular inner plug 7 having both upper and lower ends open to and from the container body 6.
  • the container body 6 includes a hollow and bottomed body 60 and a tubular body 61 integrally formed with the body 60 and having both upper and lower ends open.
  • the container body 60 is preferably transparent or translucent in part or in whole, whereby the remaining amount of the chemical solution can be confirmed from the outside.
  • the material of the container body 60 is not particularly limited, and examples thereof include synthetic resin and glass.
  • the body 60 includes a bottom portion 62, a peripheral wall portion 63 rising from the outer peripheral edge of the bottom portion 62, and a shoulder portion 64 connected to the upper end of the peripheral wall portion 63 so as to face the bottom portion 62.
  • the internal space of the body 60 is the storage space 21 for the chemical solution.
  • the shoulder portion 64 has a rectangular shape in a plan view, and a tubular body 61 is connected to the center of the shoulder portion 64 so as to extend upward.
  • the bottom portion 62 is not particularly limited, but exhibits a rectangular shape in a plan view.
  • the bottom portion 62 preferably has a central portion raised from the outer peripheral edge portion, whereby the drug container 2 can be stably placed on a horizontal table.
  • a liquid pool portion 65 is provided on the inner bottom surface of the bottom portion 62.
  • the liquid pool portion 65 is formed by denting a part of the inner bottom surface of the bottom portion 62 in a concave shape.
  • the liquid pool portion 65 is not particularly limited, but has a circular shape in a plan view, and is preferably located at the center of the bottom portion 62.
  • the liquid pool portion 65 When the liquid pool portion 65 is provided on the inner bottom surface of the bottom portion 62, the remaining amount of the chemical solution in the drug container 2 is reduced and the liquid level becomes near the inner bottom surface of the bottom portion 62, the chemical solution is liquid due to surface tension. It is pulled toward the pool portion 65 and gathers in the liquid pool portion 65. Since the lower end portion of the liquid absorbing core material 3 is located directly above the liquid collecting portion 65, the chemical liquid collected in the liquid collecting portion 65 can be sucked up by the lower end portion of the liquid absorbing core material 3.
  • the drug solution can be satisfactorily sucked up by the liquid absorbing core material 3 and the drug component can be volatilized in the external space.
  • the liquid pool portion 65 preferably has an outer diameter m smaller than the outer diameter L at least at the lower end of the liquid absorbing core material 3 and has a size of being covered from above by the liquid absorbing core material 3.
  • the outer diameter m of the liquid pool portion 65 refers to the outer diameter of the opening edge opened at the inner bottom surface of the bottom portion 62 of the liquid pool portion 65 (the outer diameter at the height of the inner bottom surface of the liquid pool portion 65).
  • the liquid absorbing core material 3 As will be described later, depending on the specifications of the liquid absorbing core material 3, it may be difficult to suck up the chemical solution from the outer peripheral surface of the liquid absorbing core material 3, for example, the liquid absorbing core material 3 is subjected to a treatment for improving the strength of the outer peripheral surface. In this case, it is necessary to suck up more chemical solution from the lower end surface of the liquid absorbing core material 3. Since the liquid collecting portion 65 is covered with the liquid absorbing core material 3 from above, the chemical liquid collected in the liquid collecting portion 65 can be efficiently sucked up from the lower end surface of the liquid absorbing core material 3. Therefore, even if the liquid-absorbent core material 3 has the above-mentioned specifications, the liquid-absorbent core material 3 can suck up all the chemicals in the drug container 2 as much as possible and use up the chemicals to the end.
  • the shoulder portion 64 is not particularly limited, but is one size smaller than the peripheral wall portion 63 and has a stepped portion 66 between the shoulder portion 64 and the peripheral wall portion 63.
  • a plurality of (four in this embodiment) recesses that can be hooked and fastened to a plurality of (four in this embodiment) engaging protrusions 52 (shown in FIG. 7) of the cover 5 described later in the step portion 66. 67 are formed at equal intervals in the circumferential direction.
  • the tubular body 61 is not particularly limited, but has a cylindrical shape, and the cross-sectional view shape of the inner wall surface and the outer wall surface is circular.
  • the cross-sectional view shape is a shape of a cross section along the horizontal direction.
  • the tubular body 61 is preferably located directly above the liquid pool portion 65 in the center of the bottom portion 61, and the center of the tubular body 61 and the center of the bottom portion 62 are in the same linear shape.
  • a male screw 68 is provided on the outer peripheral surface of the tubular body 61. The male screw 68 is screwed with the female screw 42 (shown in FIG.
  • the means for attaching the cap 4 to the mouth 20 of the drug container 2 and connecting the two is not particularly limited, and various other known means can be used.
  • the inner plug 7 can be attached to and detached from the cylinder 61 of the container body 6.
  • the mouth portion 20 of the drug container 2 is formed by the tubular body 61 and the inner plug 7, and the liquid absorbing core material 3 is inserted into the inner plug 7.
  • the inner plug 7 is not particularly limited, but has a cylindrical shape, and the cross-sectional view of the inner wall surface and the outer wall surface is circular.
  • the inner plug 7 is formed to have an outer diameter that can be fitted inside the cylinder 60, and the inner plug 7 is held inside the cylinder 60.
  • the inner plug 7 is not particularly limited, but has a fitting portion 70 on the upper side in the height direction in which the outer wall surface abuts on the inner wall surface of the cylinder 61 and is fitted into the cylinder 61, and an inner diameter slightly larger than that of the fitting portion 70. It also includes a holding portion 71 on the lower side in the height direction having a small outer diameter, and a tapered portion 72 connecting the fitting portion 70 and the holding portion 71.
  • the fitting portion 70 has an inner diameter larger than the outer diameter L of the liquid absorbing core material 3, and the inner wall surface of the fitting portion 70 does not come into contact with the outer peripheral surface of the liquid absorbing core material 3 inserted into the inner plug 7, and the liquid absorbing core material A gap is formed between the three and the third.
  • a flange portion 73 horizontally protrudes outward from the upper end of the fitting portion 70.
  • the inner diameter l of the sandwiching portion 71 is smaller than the outer diameter L of the liquid absorbing core material 3, that is, the cross-sectional view shape of the inner wall surface is smaller than the cross-sectional view shape of the liquid absorbing core material 3. Therefore, the inner wall surface of the holding portion 71 presses the outer peripheral surface of the liquid absorbing core material 3 inserted into the inner plug 7.
  • the liquid-absorbent core material 3 is inserted into the holding portion 71 while being pushed in, the liquid-absorbent core material 3 is deformed so as to shrink in diameter (the outer peripheral surface is constricted) as shown in FIG.
  • the outer peripheral surface abuts on the inner wall surface of the sandwiching portion 71 and is sandwiched by the sandwiching portion 71.
  • the liquid absorbing core material 3 is attached to the mouth portion 20 of the drug container 2 and is held in the drug container 2 without easily coming out of the mouth portion 20.
  • the inner and outer diameters of the tapered portion 72 gradually decrease toward the bottom.
  • the liquid-absorbent core material 3 is gradually deformed by the tapered portion 72 so as to reach the sandwiching portion 71, so that the liquid-absorbing core material 3 is inserted into the sandwiching portion 71. It can be inserted smoothly inside.
  • the material of the inner plug 7 is not particularly limited, but for example, polyethylene terephthalate or the like can be mentioned more specifically than the synthetic resin.
  • the liquid-absorbent core material 3 is a rod-shaped member that extends linearly before being inserted into the drug container 2, and is not particularly limited, but exhibits a columnar shape having a circular cross-sectional view. Further, the liquid absorbing core material 3 is not particularly limited, but exhibits a circular shape having substantially the same outer diameter L in cross-sectional view over the entire length and the thickness is substantially the same over the entire length.
  • the liquid absorbing core material 3 is inserted into the drug container 2 from the mouth portion 20 and used.
  • the length of the liquid absorbing core material 3 is such that the lower end reaches the inner bottom surface of the drug container 2 and a part of the upper end side can protrude upward from the mouth portion 20 of the drug container 2. Since the lower end of the liquid-absorbing core material 3 reaches the inner bottom surface of the drug container 2, the drug solution can be sucked up by the liquid-absorbing core material 3 even if the remaining amount of the drug solution in the drug container 2 is low.
  • the material of the liquid-absorbing core material 3 is not particularly limited as long as the chemical solution in the drug container 2 can be sucked up by the capillary phenomenon and the sucked-up drug solution can be volatilized in the external space.
  • various materials such as nylon, polyester (for example, polyethylene terephthalate), polypropylene, polyethylene, polyoxymethylene, isoparaffin, cellulose, rattan, and pulp can be mentioned as the material of the liquid absorbing core material 3, and these materials are one kind. It may be used alone or in combination of two or more.
  • liquid absorbing core material 3 for the purpose of suppressing deformation of the liquid absorbing core material 3 at high temperatures and maintaining a stable shape of the liquid absorbing core material 3, other suitable materials may be used as the liquid absorbing core material. It may be further used as the material of 3.
  • liquid-absorbing core material 3 for example, in order to satisfactorily suck up the chemical solution, for example, a material obtained by welding or adhering a fibrous material to form a rod, a material obtained by knitting a fibrous material into a rod, or a fibrous material was used.
  • a non-woven fabric in the shape of a rod or a sponge in the shape of a rod can be used.
  • the liquid absorbing core material 3 is not particularly limited, but may be treated, for example, to improve the strength of the outer peripheral surface. As a result, even if the user holds the liquid absorbing core material 3 by hand and the outer peripheral surface is rubbed many times when the liquid absorbing core material 3 is inserted into the drug container 2, the liquid absorbing core material 3 can be fluffed and absorbed. It is possible to prevent the liquid core material 3 from being damaged.
  • the outer diameter L of the liquid absorbing core material 3 is longer than the inner diameter l of the holding portion 71 of the mouth portion 20.
  • a part in the wedge direction is sandwiched by the sandwiching portion 71, and the portion sandwiched by the sandwiching portion 71 is deformed so as to have a reduced diameter.
  • the liquid-absorbing core material 3 inserted into the drug container 2 is tightened by the holding portion 71 of the mouth portion 20, so that the capillaries of the liquid-absorbing core material 3 become thin, and the function of sucking up the chemical liquid by the capillary phenomenon is performed. Be promoted.
  • the amount of the chemical liquid sucked up by the liquid absorbing core material 3 increases, and it is difficult for the liquid absorbing core material 3 to suck up the chemical liquid from the outer peripheral surface by performing a treatment for improving the strength of the outer peripheral surface of the liquid absorbing core material 3, for example. Even when the specifications are specified, the liquid absorbing core material 3 can suck up a sufficient amount of the chemical liquid from the lower end surface and satisfactorily volatilize the chemical components into the external space.
  • the outer diameter L of the liquid absorbing core material 3 is not particularly limited, but from the viewpoint of effectively promoting the function of sucking up the chemical liquid due to the capillary phenomenon by tightening by the mouth portion 20 of the above-mentioned drug container 2, the holding portion 71
  • the inner diameter l is preferably 1.05 times or more, and more preferably 1.1 times or more. Further, although it depends on the ease of deformation of the liquid absorbing core material 3, the outer diameter L of the liquid absorbing core material 3 is the holding portion from the viewpoint of allowing the liquid absorbing core material 3 to pass through the holding portion 71 without difficulty.
  • the inner diameter l of 71 is preferably 1.5 times or less, and more preferably 1.2 times or less.
  • the length of the portion of the liquid absorbing core material 3 that is sandwiched by the sandwiching portion 71, that is, the height of the sandwiching portion 71 is not particularly limited, but the drug solution due to the capillary phenomenon due to the tightening by the mouth portion 20 of the drug container 2 described above is not particularly limited. From the viewpoint of effectively promoting the suction function, it is preferably 1/5 or more and 4/5 or less of the total length of the liquid absorbing core material 3, and more preferably 2/5 or more and 3/5 or less.
  • the cap cap 4 is for sealing a part of the liquid absorbing core material 3 exposed above the drug container 2 when the drug volatilizer 1 is not used.
  • the cap 4 is not particularly limited, but is made of synthetic resin, and as shown in FIGS. 2 and 6, the cap 4 has a cylindrical covering portion 40 having a closed upper end and an open lower end, and an outer diameter larger than that of the covering portion 40. It includes a large and centrally connected cylindrical mounting portion 41 such that the covering portion 40 extends upward.
  • the covering portion 40 has an inner diameter and a height capable of accommodating a portion of the liquid absorbing core material 3 exposed above the drug container 2 inside.
  • the mounting portion 41 has an inner diameter that allows the mouth portion 20 of the drug container 2 to be fitted inward.
  • a female screw 42 screwed with a male screw 68 provided on the outer peripheral surface of the mouth portion 20 of the drug container 2, specifically, the outer peripheral surface of the tubular body 61 is provided.
  • the cover cover 5 is for improving the aesthetic appearance of the drug volatilizer 1 when the drug volatilizer 1 is used.
  • the cover 5 is not particularly limited, but is made of synthetic resin, and as shown in FIGS. 1, 2, and 7, a top surface portion 50 having a rectangular shape in a plan view and a peripheral surface portion 51 hanging from the outer peripheral edge of the top surface portion 50. And include.
  • the peripheral surface portion 51 can fit the shoulder portion 64 of the drug container 2 inward, and the shoulder portion 64 fits inside the peripheral surface portion 51.
  • a plurality of engaging protrusions 52 protruding inward are provided at intervals in the circumferential direction.
  • the plurality of engaging protrusions 52 engage with the recesses 67 of the stepped portion 66 of the drug container 2.
  • the cap 4 is attached to the mouth 20 of the drug container 2, and the liquid absorbing core material 3 is sealed. Therefore, at the start of use, the cap 4 is removed from the mouth 20 of the drug container 2 with the bottom 62 of the drug container 2 facing down and the cap 4 facing up. As a result, the liquid absorbing core material 3 is exposed, the chemical liquid in the drug container 2 is sucked up by the liquid absorbing core material 3, and the chemical components of the chemical liquid are continuously volatilized in the external space. As a result, the space in which the drug volatilizer 1 is installed can be made a comfortable space. While the drug volatilizer 1 is in use, the cover 5 can be attached to the drug container 2 as needed.
  • the drug volatilizer 1 of the present embodiment described above is provided with a liquid pool portion 65 on the inner bottom surface of the bottom portion 62. Therefore, when the remaining amount of the chemical solution in the drug container 2 decreases and the liquid level becomes near the inner bottom surface of the bottom portion 62, the chemical solution is pulled toward the liquid pool portion 65 by the surface tension and the liquid pool portion Gather at 65. Since the lower end portion of the liquid absorbing core material 3 is located directly above the liquid collecting portion 65, the chemical liquid collected in the liquid collecting portion 65 can be sucked up by the lower end portion of the liquid absorbing core material 3.
  • the liquid absorbing core material 3 satisfactorily sucks up the drug solution to the outside.
  • the drug component can be volatilized in the space.
  • the liquid pool portion 65 has an outer diameter smaller than the outer diameter of at least the lower end of the liquid absorbing core material 3, and is covered from above by the liquid absorbing core material 3. Therefore, the lower end surface of the liquid absorbing core material 3 faces the liquid collecting portion 65 as a whole. For example, depending on the specifications of the liquid absorbing core material 3, it may be difficult to suck up the chemical liquid from the outer peripheral surface of the liquid absorbing core material 3, such as processing to improve the strength of the outer peripheral surface of the liquid absorbing core material 3. Since the 65 is covered with the liquid absorbing core material 3 from above, the chemical liquid collected in the liquid collecting portion 65 can be efficiently sucked up from the lower end surface of the liquid absorbing core material 3.
  • the liquid absorbing core material 3 can suck up all the chemical liquid in the drug container 2 as much as possible and use up the chemical liquid to the end.
  • the cross-sectional view of the liquid absorbing core material 3 is circular, and the cross-sectional view of the inner wall surface of the holding portion 71 of the mouth portion 20 of the drug container 2 is circular. Since the outer diameter of the liquid absorbing core material 3 is larger than the inner diameter of the holding portion 71, the liquid absorbing core material 3 abuts on the inner wall surface of the holding portion 71 over the entire circumference of the outer peripheral surface of the holding portion 71. However, it is not necessary to bring the entire circumference of the outer peripheral surface of the liquid absorbing core material 3 into contact with the inner wall surface of the sandwiching portion 71.
  • a slit is formed, and the inside and outside of the medicine container 2 are communicated with the storage space 21 of the medicine container 2 and the outside space without contacting the liquid absorbing core material 3 with the inner wall surface of the holding portion 71 at the portion where the slit is located. Air may be able to flow.
  • the cross-sectional view of the liquid-absorbent core material 3 is circular, but as another modification, the cross-sectional view of the liquid-absorbent core material 3 is, for example, triangular or square. It may be a polygonal shape or various other shapes such as an elliptical shape.
  • the cross-sectional view of the liquid-absorbing core material 3 is cross-sectionally formed by making the diameter of the inscribed circle S1 larger than the inner diameter of the sandwiching portion 71.
  • the cross-sectional view shape of the inner wall surface of the holding portion 71 can be made smaller than the cross-sectional view shape of the portion sandwiched by the holding portion 71 of the liquid absorbing core material 3, whereby the liquid absorbing core material 3 can be made smaller.
  • a part of the outer peripheral surface thereof is pressed by the inner wall surface of the sandwiching portion 71.
  • the cross-sectional view of the inner wall surface of the holding portion 71 of the mouth portion 20 of the drug container 2 is circular, but as another modification, the cross-sectional view of the inner wall surface of the holding portion 71 is seen.
  • the shape may be a polygonal shape such as a triangle shape or a quadrangular shape, or may be various other shapes such as an elliptical shape.
  • the outer diameter of the liquid absorbing core material 3 is made larger than the diameter of the circle S2 inscribed in the cross-sectional view shape of the inner wall surface of the holding portion 71, whereby the liquid absorbing core material is made larger.
  • the cross-sectional view shape of 3 When the cross-sectional view shape of 3 is superimposed on the cross-sectional view shape of the inner wall surface of the holding portion 71, a part of the cross-sectional view shape of the liquid absorbing core material 3 is outside the cross-sectional view shape of the inner wall surface of the holding portion 71. It sticks out. Therefore, the cross-sectional view shape of the inner wall surface of the holding portion 71 can be made smaller than the cross-sectional view shape of the portion sandwiched by the holding portion 71 of the liquid absorbing core material 3, whereby the liquid absorbing core material 3 can be made smaller. In the portion sandwiched by the sandwiching portion 71, a part of the outer peripheral surface thereof is pressed by the inner wall surface of the sandwiching portion 71. As a result, since the liquid-absorbing core material 3 inserted into the drug container 2 is tightened by the holding portion 71 of the mouth portion 20, it is possible to promote the function of sucking up the drug solution due to the capillary phenomenon of the liquid-absorbing core material 3.
  • the cross-sectional view shape of the liquid absorbing core material 3 may be a shape other than the circular shape, and the cross-sectional view shape of the inner wall surface of the holding portion 71 may be a shape other than the circular shape. Also in this modification, although not shown, the cross-sectional view shape of the liquid-absorbent core material 3 when the cross-sectional view shape of the liquid-absorbent core material 3 is superimposed on the cross-sectional view shape of the inner wall surface of the holding portion 71.
  • the cross-sectional view shape of both By designing the cross-sectional view shape of both so that a part of the above is projected to the outside of the cross-sectional view shape of the inner wall surface of the holding portion 71, the cross-sectional view shape of the inner wall surface of the holding portion 71 can be changed to the liquid absorbing core material 3. It can be made smaller than the cross-sectional view shape of the portion sandwiched by the sandwiching portion 71.
  • the liquid absorbing core material 3 exhibits a circular shape having substantially the same outer diameter in cross-sectional view over the entire length, but as another modification, at least a portion sandwiched by the sandwiching portion 71 has a cross-sectional cross section.
  • the visual shape may be larger than the cross-sectional visual shape of the inner wall surface of the sandwiching portion 71.
  • the outer diameter of the portion sandwiched by the sandwiching portion 71 of the liquid absorbing core material 3 is made larger than the inner diameter of the sandwiching portion 71, preferably 1.05. It is doubled or more, more preferably 1.1 times or more.
  • the mouth portion 20 of the drug container 2, specifically, the inner plug 7, has a different size (inner diameter) in cross-sectional view between the holding portion 71 and the fitting portion 70, but other
  • the same size (inner diameter) as the cross-sectional view shape of the sandwiching portion 71 may be used in all directions in the height direction.
  • the drug container 2 includes the container body 6 and the inner plug 7, and the mouth portion 20 is composed of the tubular body 61 and the inner plug 7 of the container body 6, but as another modification, the mouth The portion 20 may be composed of only the tubular body 61 of the container body 6.
  • the tubular body 61 of the container body 6 is formed so as to include the holding portion having the same structure as the holding portion 71 of the inner plug 7.
  • the liquid pool portion 65 is located at the center of the inner bottom surface of the bottom portion 62 of the drug container 2, but as another modification, if it is within the range covered by the liquid absorbing core material 3 from above. , The position may be displaced from the center of the inner bottom surface of the drug container 2.
  • the tubular body 61 of the drug container 2 is located directly above the center of the bottom portion 62, but as another modification, the tubular body 61 may be displaced from directly above the center of the bottom portion 62. Accordingly, the liquid pool portion 65 is located on the inner bottom surface of the bottom portion 62 of the drug container 2 as long as it is within the range covered from above by the liquid absorbing core material 3 inserted into the drug container 2 from the tubular body 61. You may be doing it.
  • the liquid-absorbent core material 3 is inserted into the drug container 2 so as to stand upright in the drug container 2 in the vertical direction, but as another modification, the liquid-absorbent core material 3 is a drug. It may be inserted into the drug container 2 so as to face diagonally in the container 2, and the liquid pool portion 65 is covered from above by the liquid absorbing core material 3 inserted into the drug container 2 from the tubular body 61 accordingly. It may be located anywhere on the inner bottom surface of the bottom portion 62 of the drug container 2 as long as it is within the specified range.

Abstract

Provided is a chemical agent volatizer capable of satisfactorily absorbing a chemical solution by means of a liquid-absorbing core material when the remaining amount of chemical solution inside a chemical agent container has decreased. A chemical agent volatizer 1 comprises: a chemical agent container 2 that accommodates a liquid chemical agent; and a liquid-absorbing core material 3 that has a lower end that reaches the inner bottom surface of the chemical agent container 2, that is inserted inside the chemical agent container such that the upper end portion protrudes upward from the chemical agent container 2, and that draws up a liquid chemical solution. The inner bottom surface of the chemical agent container 2 is provided with a liquid reservoir portion 65 that is recessed at a location reached by the lower end of the liquid-absorbing core material 3.

Description

薬剤揮散器Drug volatilizer
 本発明は、芳香液や消臭液などの液状の薬剤を収容した薬剤容器内に吸液芯材を挿入し、吸液芯材により液状の薬剤を吸い上げて薬剤容器の外部の空間(本開示では「外部空間」という。)に揮散させる薬剤揮散器に関する。 INDUSTRIAL APPLICABILITY According to the present invention, a liquid absorbing core material is inserted into a drug container containing a liquid drug such as an aromatic liquid or a deodorant, and the liquid drug is sucked up by the liquid absorbing core material to create a space outside the drug container (the present disclosure). Then, it is related to the drug volatilizer that volatilizes in the "external space").
 室内や車内などの空間の臭気による不快感をなくし、快適な空間を生み出すために、芳香剤、消臭剤などの薬剤を自然に揮散させる薬剤揮散器が広く使用されている。この薬剤揮散器には、ゲル状、固形状、液状など、種々の薬剤が用いられており、その中で液状の薬剤(本開示では「薬液」ともいう。)を用いた薬剤揮散器として、例えば特許文献1に記載の薬剤揮散器が知られている。 In order to eliminate the discomfort caused by the odor of spaces such as indoors and cars and create a comfortable space, chemical volatilizers that naturally volatilize chemicals such as air fresheners and deodorants are widely used. Various chemicals such as gel, solid, and liquid are used in this drug volatilizer, and among them, a liquid drug (also referred to as "drug solution" in the present disclosure) is used as a drug volatilizer. For example, the drug volatilizer described in Patent Document 1 is known.
 薬液を用いた薬剤揮散器は、薬液を収容する薬剤容器と、薬剤容器内に挿入される棒状の吸液芯材とを備える。吸液芯材は、下端が薬剤容器の内底面に達しかつ上端側の一部分が薬剤容器から上方に突き出るように薬剤容器の口部に保持され、薬液を毛細管現象により吸い上げて外部空間に揮散する。 The drug volatilizer using the drug solution includes a drug container for accommodating the drug solution and a rod-shaped liquid absorbing core material inserted into the drug container. The liquid-absorbent core material is held at the mouth of the drug container so that the lower end reaches the inner bottom surface of the drug container and a part of the upper end side protrudes upward from the drug container, and the drug solution is sucked up by capillarity and volatilized into the external space. ..
特開2017-095122号公報Japanese Unexamined Patent Publication No. 2017-095122
 上述した吸液芯材を用いて薬液を吸い上げる薬剤揮散器においては、薬剤容器内の薬液の残量が減少した場合(薬剤容器内の薬液の液面の高さが薬剤容器の底部の上面(本開示では「内底面」という。)に近くなった場合)に、吸液芯材の仕様(例えば外周面の強度を向上させる処理を行うことで外周面からは薬液を吸収しにくい仕様)によっては吸液芯材により薬剤容器内の薬液を全て吸い上げることが難しいケースがあり、その場合、薬液を最後まで使い切れないという課題がある。 In the drug volatilizer that sucks up the drug solution using the above-mentioned liquid absorbing core material, when the remaining amount of the drug solution in the drug container decreases (the height of the liquid level of the drug solution in the drug container is the upper surface of the bottom of the drug container ( In this disclosure, it is referred to as "inner bottom surface"), depending on the specifications of the liquid-absorbing core material (for example, specifications that make it difficult to absorb chemicals from the outer peripheral surface by performing a treatment to improve the strength of the outer peripheral surface). In some cases, it is difficult to suck up all the chemicals in the drug container with the liquid absorbing core material, and in that case, there is a problem that the chemicals cannot be used up to the end.
 本発明は、上記課題に着目してなされたものであり、薬剤容器内の薬液の残量が減少した場合に吸液芯材により良好に薬液を吸い上げることできる薬剤揮散器を提供することを目的とする。 The present invention has been made focusing on the above-mentioned problems, and an object of the present invention is to provide a drug volatilizer capable of sucking up a drug solution satisfactorily with a liquid absorbing core material when the remaining amount of the drug solution in the drug container is reduced. And.
 本発明は、液状の薬剤を収容した薬剤容器内に吸液芯材を挿入し、吸液芯材により液状の薬剤を吸い上げて外部空間に揮散させる薬剤揮散器に関する。本発明の薬剤揮散器は、液状の薬剤を収容する薬剤容器と、下端が薬剤容器の内底面に到達しかつ上端側の一部分が前記薬剤容器から上方に突き出るように前記薬剤容器内に挿入される吸液芯材であって、前記液状の薬剤を吸い上げる吸液芯材と、を備え、前記薬剤容器の内底面には前記吸液芯材の下端が到達する位置に凹状にへこむ液溜まり部が設けられる、ことを特徴とする。 The present invention relates to a drug volatilizer in which a liquid absorbing core material is inserted into a drug container containing a liquid drug, and the liquid drug is sucked up by the liquid absorbing core material and volatilized in an external space. The drug volatilizer of the present invention is inserted into the drug container so that the drug container containing the liquid drug and the lower end of the drug container reach the inner bottom surface of the drug container and a part of the upper end side protrudes upward from the drug container. A liquid-absorbing core material that is provided with a liquid-absorbing core material that sucks up the liquid drug, and a liquid pool portion that is concavely dented at a position where the lower end of the liquid-absorbing core material reaches the inner bottom surface of the drug container. Is provided.
 本発明の薬剤揮散器において好ましくは、前記液溜まり部は、前記吸液芯材により上方から覆われる大きさをなす、ことを特徴とするように構成することができる。 The drug volatilizer of the present invention is preferably configured such that the liquid pool portion has a size of being covered from above by the liquid absorbing core material.
 また、本発明の薬剤揮散器において好ましくは、前記吸液芯材の横断面視形状が円形状であり、前記液溜まり部の平面視形状が円形状であり、前記液溜まり部の外径が前記吸液芯材の下端における内径よりも小さい、ことを特徴とするように構成することができる。 Further, in the chemical volatilizer of the present invention, the cross-sectional view of the liquid absorbing core material is preferably circular, the plan view of the liquid pool is circular, and the outer diameter of the liquid pool is large. It can be configured to be smaller than the inner diameter at the lower end of the liquid absorbing core material.
 また、本発明の薬剤揮散器において好ましくは、前記液溜まり部が前記薬剤容器の内底面の中央に位置する、ことを特徴とするように構成することができる。 Further, the drug volatilizer of the present invention is preferably configured such that the liquid pool portion is located at the center of the inner bottom surface of the drug container.
 本発明の薬剤揮散器によれば、薬剤容器内の薬液の残量が減少した場合に吸液芯材により良好に薬液を吸い上げることできる。 According to the drug volatilizer of the present invention, when the remaining amount of the drug solution in the drug container is reduced, the drug solution can be satisfactorily sucked up by the liquid absorbing core material.
本実施形態の薬剤揮散器の斜視図である。It is a perspective view of the drug volatilizer of this embodiment. 本実施形態の薬剤揮散器の分解斜視図である。It is an exploded perspective view of the drug volatilizer of this embodiment. キャップ及びカバーを取り外した状態の本実施形態の薬剤揮散器の平面図である。It is a top view of the drug volatilizer of this embodiment with a cap and a cover removed. キャップ及びカバーを取り外した状態の本実施形態の薬剤揮散器の縦断面図である。It is a vertical sectional view of the drug volatilizer of this embodiment with a cap and a cover removed. 図4の薬剤容器の底部側を拡大して示す(A)縦断面図、(B)横断面図である。FIG. 4 is an enlarged vertical sectional view (A) and a horizontal sectional view (B) showing the bottom side of the drug container of FIG. 4. 本実施形態の薬剤揮散器において薬剤容器にキャップを装着した状態の平面図である。It is a top view of the state which attached the cap to the medicine container in the medicine volatilizer of this embodiment. 本実施形態の薬剤揮散器において薬剤容器にカバーを装着した状態の平面図である。It is a top view of the state which attached the cover to the medicine container in the medicine volatilizer of this embodiment. 変形例の薬剤揮散器において吸液芯材と薬剤容器の口部の挟持部との関係を示す説明図である。It is explanatory drawing which shows the relationship between the liquid-absorbing core material and the holding part of the mouth part of a drug container in the drug volatilizer of the modified example. 変形例の薬剤揮散器において吸液芯材と薬剤容器の口部の挟持部との関係を示す説明図である。It is explanatory drawing which shows the relationship between the liquid-absorbing core material and the holding part of the mouth part of a drug container in the drug volatilizer of the modified example.
 本発明の薬剤揮散器は、揮散性を有する液状の薬剤(薬液)を収容した薬剤容器内に吸液芯材を挿入し、吸液芯材の毛細管現象により薬液を吸い上げて薬液の薬剤成分を外部空間に揮散させるものである。本発明の薬剤揮散器は、例えば室内や車内などの空間の臭気による不快感をなくして快適な空間を生み出すために、芳香液や消臭液などを薬液とし、芳香剤成分や消臭剤成分などを自然に揮散させて芳香や消臭などの薬効を得る目的で使用される。なお、本発明の薬剤揮散器の上述した使用目的はあくまでも一例である。 In the drug volatilizer of the present invention, a liquid absorbing core material is inserted into a drug container containing a liquid drug (drug solution) having volatilization property, and the drug solution is sucked up by the capillary phenomenon of the liquid absorbing core material to release the drug component of the drug solution. It is to be volatilized in the external space. The chemical volatilizer of the present invention uses a fragrance liquid, a deodorant liquid, or the like as a chemical liquid in order to eliminate the discomfort caused by the odor of a space such as a room or a car, and to use a fragrance liquid or a deodorant component as a chemical liquid. It is used for the purpose of obtaining medicinal effects such as fragrance and deodorization by naturally volatilizing such substances. The above-mentioned purpose of use of the drug volatilizer of the present invention is merely an example.
 以下、本発明の薬剤揮散器の実施形態について、添付図面を参照して説明する。なお、本開示では、自立する薬剤揮散器の高さ方向を上下方向とする。 Hereinafter, embodiments of the drug volatilizer of the present invention will be described with reference to the attached drawings. In this disclosure, the height direction of the self-supporting drug volatilizer is the vertical direction.
薬剤揮散器
 図1及び図2に示すように、薬剤揮散器1は、薬液を収容する薬剤容器2及び薬剤容器2内に挿入される吸液芯材3を備える。また、薬剤揮散器1は、好ましくは薬剤容器2に対して着脱可能なキャップ4及びカバー5をさらに備える。
Drug Volatilizer As shown in FIGS. 1 and 2, the drug volatilizer 1 includes a drug container 2 for accommodating a drug solution and a liquid absorbing core material 3 inserted into the drug container 2. Further, the drug volatilizer 1 preferably further includes a cap 4 and a cover 5 that can be attached to and detached from the drug container 2.
 図3に示すように、吸液芯材3は、下端が薬剤容器2の底部62の上面(本開示では「内底面」という。)に到達しかつ上端側の一部分が薬剤容器2から上方に突き出るように、薬剤容器2の口部20に保持される。吸液芯材3は、薬液と接触する部分において薬液を毛細管現象により吸い上げることで、薬剤成分を外部空間に揮散させる。 As shown in FIG. 3, the lower end of the liquid absorbing core material 3 reaches the upper surface of the bottom portion 62 of the drug container 2 (referred to as “inner bottom surface” in the present disclosure), and a part of the upper end side is upward from the drug container 2. It is held in the mouth 20 of the drug container 2 so as to protrude. The liquid-absorbing core material 3 sucks up the chemical solution by a capillary phenomenon at a portion in contact with the chemical solution, thereby volatilizing the drug component into the external space.
 図6に示すように、キャップ4は、吸液芯材3の薬剤容器2から上方に突き出る部分を覆うように薬剤容器2の口部20に装着される。吸液芯材3はキャップ4により概ね密封されて外部空間から遮断されるので、キャップ4を薬剤容器2に装着した状態では、薬液の薬剤成分は吸液芯材3から連続的に揮散せず、外部空間に放出されない。そのため、キャップ4は薬剤揮散器1の非使用時に用いられ、使用時には薬剤容器2の口部20から取り外される。キャップ4を薬剤容器2の口部20から取り外すと、吸液芯材3により吸い上げられた薬液の薬剤成分が揮散して外部空間に放出され、薬剤揮散器1は薬効を発揮する。 As shown in FIG. 6, the cap 4 is attached to the mouth portion 20 of the drug container 2 so as to cover the portion of the liquid absorbing core material 3 that protrudes upward from the drug container 2. Since the liquid-absorbent core material 3 is largely sealed by the cap 4 and shielded from the external space, the drug component of the chemical solution does not continuously volatilize from the liquid-absorbent core material 3 when the cap 4 is attached to the drug container 2. , Not released into the external space. Therefore, the cap 4 is used when the drug volatilizer 1 is not used, and is removed from the mouth 20 of the drug container 2 when used. When the cap 4 is removed from the mouth 20 of the drug container 2, the drug component of the drug solution sucked up by the liquid absorbing core material 3 is volatilized and released to the external space, and the drug volatilizer 1 exerts its medicinal effect.
 図7に示すように、カバー5は、薬剤揮散器1の使用時に主に用いられ、薬剤揮散器1のデザイン的な観点から、吸液芯材3の薬剤容器2から突き出る部分を外部から視認し難くするために薬剤容器2に装着される。カバー5には複数の揮散孔53が形成されており、カバー5を薬剤容器2に装着した状態では、吸液芯材3から揮散した薬液の薬剤成分はカバー5のそれぞれの揮散孔53を通過して外部空間に放出される。 As shown in FIG. 7, the cover 5 is mainly used when the drug volatilizer 1 is used, and from the design viewpoint of the drug volatilizer 1, the portion of the liquid absorbing core material 3 protruding from the drug container 2 can be visually recognized from the outside. It is attached to the drug container 2 to make it difficult to do. A plurality of volatilization holes 53 are formed in the cover 5, and when the cover 5 is attached to the drug container 2, the drug component of the drug solution volatilized from the liquid absorbing core material 3 passes through the respective volatilization holes 53 of the cover 5. And it is released to the external space.
 以下、薬液について説明した後、薬剤揮散器1の各構成部材について詳細に説明する。 Hereinafter, after explaining the chemical solution, each component of the chemical volatilizer 1 will be described in detail.
薬液(液状の薬剤)
 薬液は、揮散性(薬効徐放性)を有し、空気との接触により空気中に徐々に薬剤成分を揮散することで薬効を奏する。薬液は薬剤成分を含む。薬剤成分としては、例えば芳香剤成分、消臭剤成分、殺虫剤成分、防虫剤成分、忌避剤成分、抗菌剤成分などを挙げることができる。薬液は、これらの薬剤成分のうちの1つを単独で含むこともできるし、複数を組み合わせて含むこともできる。薬剤成分は揮散可能である限り、油性又は水性のいずれであってもよい。
Chemical solution (liquid drug)
The chemical solution has volatilization property (sustained release property), and exerts a medicinal effect by gradually volatilizing the drug component into the air by contact with air. The drug solution contains a drug component. Examples of the drug component include an fragrance component, a deodorant component, an insecticide component, an insect repellent component, a repellent component, an antibacterial agent component, and the like. The drug solution may contain one of these drug components alone, or may contain a plurality of them in combination. The drug component may be either oily or aqueous as long as it can be volatilized.
 薬液の粘度は、特に限定されないが、25℃環境下で、0.1mPa・s以上30mPa・s以下であることが好ましく、0.1mPa・s以上20mPa・s以下であることがより好ましく、0.1mPa・s以上10mPa・s以下であることがさらに好ましい。薬液の粘度は、振動式粘度計(VM-3OO-L  セコニック社製)を用いて、25℃環境下で測定することができる。 The viscosity of the chemical solution is not particularly limited, but is preferably 0.1 mPa · s or more and 30 mPa · s or less, more preferably 0.1 mPa · s or more and 20 mPa · s or less, and 0. It is more preferable that it is 1 mPa · s or more and 10 mPa · s or less. The viscosity of the chemical solution can be measured in an environment of 25 ° C. using a vibration viscometer (VM-3OO-L manufactured by Sekonic).
薬剤容器
 図2~図4に示すように、薬剤容器2は上下両端が開口した口部20を有し、吸液芯材3は口部20から薬剤容器2内に挿し込まれる。また、吸液芯材3は口部20に保持されることで、薬剤容器2から抜け出にくくされている。薬剤容器2は、好ましくは容器本体6と、容器本体6に着脱可能である上下両端が開口した筒状の中栓7とにより構成される。
Drug container As shown in FIGS. 2 to 4, the drug container 2 has a mouth portion 20 having both upper and lower ends open, and the liquid absorbing core material 3 is inserted into the drug container 2 from the mouth portion 20. Further, the liquid absorbing core material 3 is held in the mouth portion 20 to prevent it from coming out of the drug container 2. The drug container 2 is preferably composed of a container body 6 and a tubular inner plug 7 having both upper and lower ends open to and from the container body 6.
 容器本体6は、中空かつ有底の胴体60と、胴体60に一体形成された上下両端が開口した筒状の筒体61とを含む。容器本体60は、好ましくは一部又は全体が透明又は半透明であり、これにより外部から薬液の残量を確認することができる。容器本体60の素材としては、特に限定されないが、例えば合成樹脂やガラスなどを挙げることができる。 The container body 6 includes a hollow and bottomed body 60 and a tubular body 61 integrally formed with the body 60 and having both upper and lower ends open. The container body 60 is preferably transparent or translucent in part or in whole, whereby the remaining amount of the chemical solution can be confirmed from the outside. The material of the container body 60 is not particularly limited, and examples thereof include synthetic resin and glass.
 胴体60は、底部62、底部62の外周縁から立ち上がる周壁部63、及び底部62と対向するよう周壁部63の上端に連なる肩部64を含む。胴体60の内部空間が薬液の収容空間21である。肩部64は平面視矩形状であり、肩部64の中央には筒体61が上方に延びるように連なる。 The body 60 includes a bottom portion 62, a peripheral wall portion 63 rising from the outer peripheral edge of the bottom portion 62, and a shoulder portion 64 connected to the upper end of the peripheral wall portion 63 so as to face the bottom portion 62. The internal space of the body 60 is the storage space 21 for the chemical solution. The shoulder portion 64 has a rectangular shape in a plan view, and a tubular body 61 is connected to the center of the shoulder portion 64 so as to extend upward.
 底部62は、特に限定されないが、平面視矩形状を呈する。底部62は、好ましくは中央部が外周縁部よりも隆起しており、これにより、水平な台上に薬剤容器2を安定して載置可能である。 The bottom portion 62 is not particularly limited, but exhibits a rectangular shape in a plan view. The bottom portion 62 preferably has a central portion raised from the outer peripheral edge portion, whereby the drug container 2 can be stably placed on a horizontal table.
 図5に示すように、底部62の内底面には、液溜まり部65が設けられている。液溜まり部65は、底部62の内底面の一部を凹状にへこませることで形成される。液溜まり部65は、特に限定されないが、平面視円形状を呈しており、好ましくは底部62の中央に位置している。 As shown in FIG. 5, a liquid pool portion 65 is provided on the inner bottom surface of the bottom portion 62. The liquid pool portion 65 is formed by denting a part of the inner bottom surface of the bottom portion 62 in a concave shape. The liquid pool portion 65 is not particularly limited, but has a circular shape in a plan view, and is preferably located at the center of the bottom portion 62.
 底部62の内底面に液溜まり部65が設けられることで、薬剤容器2内の薬液の残量が減少して液面が底部62の内底面付近となった場合に、薬液は表面張力により液溜まり部65の方に向かって引っ張られて液溜まり部65に集まる。液溜まり部65の直上には吸液芯材3の下端部が位置するので、液溜まり部65に集まった薬液を吸液芯材3の下端部により吸い上げることができる。このように、液溜まり部65の存在により、薬剤容器2内の薬液の残量が減少しても、吸液芯材3により良好に薬液を吸い上げて外部空間に薬剤成分を揮散させることできる。 When the liquid pool portion 65 is provided on the inner bottom surface of the bottom portion 62, the remaining amount of the chemical solution in the drug container 2 is reduced and the liquid level becomes near the inner bottom surface of the bottom portion 62, the chemical solution is liquid due to surface tension. It is pulled toward the pool portion 65 and gathers in the liquid pool portion 65. Since the lower end portion of the liquid absorbing core material 3 is located directly above the liquid collecting portion 65, the chemical liquid collected in the liquid collecting portion 65 can be sucked up by the lower end portion of the liquid absorbing core material 3. As described above, even if the remaining amount of the chemical solution in the drug container 2 is reduced due to the presence of the liquid pool portion 65, the drug solution can be satisfactorily sucked up by the liquid absorbing core material 3 and the drug component can be volatilized in the external space.
 液溜まり部65は、好ましくは外径mが吸液芯材3の少なくとも下端の外径Lよりも小さく、吸液芯材3により上方から覆われる大きさをなす。なお、液溜まり部65の外径mは、液溜まり部65の底部62の内底面において開口する開口縁の外径(液溜まり部65の内底面の高さにおける外径)を言う。これにより、液溜まり部65上には全体的に吸液芯材3の下端面が面する。後述するように、例えば吸液芯材3について外周面の強度を向上させる処理を施すなど、吸液芯材3の仕様によっては吸液芯材3の外周面から薬液を吸い上げ難くなるケースがあり、この場合には吸液芯材3の下端面からより多くの薬液を吸い上げる必要がある。液溜まり部65が吸液芯材3により上方から覆われることにより、液溜まり部65に集まった薬液を吸液芯材3の下端面から効率よく吸い上げることができる。よって、吸液芯材3が上述した仕様であっても、吸液芯材3により薬剤容器2内の薬液を可能な限り全て吸い上げて薬液を最後まで使い切ることができる。 The liquid pool portion 65 preferably has an outer diameter m smaller than the outer diameter L at least at the lower end of the liquid absorbing core material 3 and has a size of being covered from above by the liquid absorbing core material 3. The outer diameter m of the liquid pool portion 65 refers to the outer diameter of the opening edge opened at the inner bottom surface of the bottom portion 62 of the liquid pool portion 65 (the outer diameter at the height of the inner bottom surface of the liquid pool portion 65). As a result, the lower end surface of the liquid absorbing core material 3 faces the liquid collecting portion 65 as a whole. As will be described later, depending on the specifications of the liquid absorbing core material 3, it may be difficult to suck up the chemical solution from the outer peripheral surface of the liquid absorbing core material 3, for example, the liquid absorbing core material 3 is subjected to a treatment for improving the strength of the outer peripheral surface. In this case, it is necessary to suck up more chemical solution from the lower end surface of the liquid absorbing core material 3. Since the liquid collecting portion 65 is covered with the liquid absorbing core material 3 from above, the chemical liquid collected in the liquid collecting portion 65 can be efficiently sucked up from the lower end surface of the liquid absorbing core material 3. Therefore, even if the liquid-absorbent core material 3 has the above-mentioned specifications, the liquid-absorbent core material 3 can suck up all the chemicals in the drug container 2 as much as possible and use up the chemicals to the end.
 図2~図4に示すように、肩部64は、特に限定されないが、周壁部63よりも一回り小さく、周壁部63との間に段差部66を有する。段差部66には、後述するカバー5の複数(本実施形態では4つ)の係合突起52(図7に示す)を引っ掛けてとめることが可能な複数(本実施形態では4つ)の凹部67が周方向に等間隔に形成される。段差部66の複数の凹部67にカバー5の複数の係合突起52が係合することにより、カバー5を薬剤容器2に取り付けてカバー5が薬剤容器2から容易に外れないよう両者を連結可能である。 As shown in FIGS. 2 to 4, the shoulder portion 64 is not particularly limited, but is one size smaller than the peripheral wall portion 63 and has a stepped portion 66 between the shoulder portion 64 and the peripheral wall portion 63. A plurality of (four in this embodiment) recesses that can be hooked and fastened to a plurality of (four in this embodiment) engaging protrusions 52 (shown in FIG. 7) of the cover 5 described later in the step portion 66. 67 are formed at equal intervals in the circumferential direction. By engaging the plurality of engaging protrusions 52 of the cover 5 with the plurality of recesses 67 of the step portion 66, the cover 5 can be attached to the drug container 2 and both can be connected so that the cover 5 does not easily come off from the drug container 2. Is.
 筒体61は、特に限定されないが、円筒状を呈し、内壁面及び外壁面の横断面視形状は円形状である。なお、本開示において横断面視形状とは、水平方向に沿った断面の形状である。筒体61は、好ましくは底部61の中央の液溜まり部65の真上に位置し、筒体61の中心と底部62の中心とは同一直線状にある。筒体61の外周面には雄ねじ68が設けられる。雄ねじ68は後述するキャップ4の雌ねじ42(図6に示す)と螺合し、これにより、キャップ4を薬剤容器2の口部20に取り付けてキャップ4が口部20から容易に外れないよう両者を連結可能である。なお、薬剤容器2の口部20にキャップ4を取り付けて両者を連結する手段は特に限定されず、その他の種々の公知の手段を用いることができる。 The tubular body 61 is not particularly limited, but has a cylindrical shape, and the cross-sectional view shape of the inner wall surface and the outer wall surface is circular. In the present disclosure, the cross-sectional view shape is a shape of a cross section along the horizontal direction. The tubular body 61 is preferably located directly above the liquid pool portion 65 in the center of the bottom portion 61, and the center of the tubular body 61 and the center of the bottom portion 62 are in the same linear shape. A male screw 68 is provided on the outer peripheral surface of the tubular body 61. The male screw 68 is screwed with the female screw 42 (shown in FIG. 6) of the cap 4 described later, whereby the cap 4 is attached to the mouth portion 20 of the drug container 2 so that the cap 4 does not easily come off from the mouth portion 20. Can be connected. The means for attaching the cap 4 to the mouth 20 of the drug container 2 and connecting the two is not particularly limited, and various other known means can be used.
 中栓7は容器本体6の筒体61に着脱可能である。筒体61及び中栓7により薬剤容器2の口部20が構成され、中栓7内に吸液芯材3が挿入される。中栓7は、特に限定されないが、円筒状を呈し、内壁面及び外壁面の横断面視形状は円形状である。中栓7は筒体60の内側に嵌め込むことが可能な外径に形成され、中栓7は筒体60内で保持される。 The inner plug 7 can be attached to and detached from the cylinder 61 of the container body 6. The mouth portion 20 of the drug container 2 is formed by the tubular body 61 and the inner plug 7, and the liquid absorbing core material 3 is inserted into the inner plug 7. The inner plug 7 is not particularly limited, but has a cylindrical shape, and the cross-sectional view of the inner wall surface and the outer wall surface is circular. The inner plug 7 is formed to have an outer diameter that can be fitted inside the cylinder 60, and the inner plug 7 is held inside the cylinder 60.
 中栓7は、特に限定されないが、外壁面が筒体61の内壁面に当接して筒体61内に嵌め込まれる高さ方向上側の嵌合部70と、嵌合部70よりも一回り内径及び外径の小さい高さ方向下側の挟持部71と、嵌合部70及び挟持部71をつなぐテーパー部72とを含む。 The inner plug 7 is not particularly limited, but has a fitting portion 70 on the upper side in the height direction in which the outer wall surface abuts on the inner wall surface of the cylinder 61 and is fitted into the cylinder 61, and an inner diameter slightly larger than that of the fitting portion 70. It also includes a holding portion 71 on the lower side in the height direction having a small outer diameter, and a tapered portion 72 connecting the fitting portion 70 and the holding portion 71.
 嵌合部70は、内径が吸液芯材3の外径Lよりも大きく、内壁面が中栓7内に挿入される吸液芯材3の外周面と当接せずに吸液芯材3との間に空隙を形成する。嵌合部70の上端には外側に向けてフランジ部73が水平に突き出る。中栓7を容器本体6の筒体61に取り付ける際には、フランジ部73が筒体61の上端に当接するまで中栓7を筒体61内に挿入する。 The fitting portion 70 has an inner diameter larger than the outer diameter L of the liquid absorbing core material 3, and the inner wall surface of the fitting portion 70 does not come into contact with the outer peripheral surface of the liquid absorbing core material 3 inserted into the inner plug 7, and the liquid absorbing core material A gap is formed between the three and the third. A flange portion 73 horizontally protrudes outward from the upper end of the fitting portion 70. When attaching the inner plug 7 to the cylinder 61 of the container body 6, the inner plug 7 is inserted into the cylinder 61 until the flange portion 73 abuts on the upper end of the cylinder 61.
 挟持部71は、内径lが吸液芯材3の外径Lよりも小さく、つまりは、内壁面の横断面視形状が吸液芯材3の横断面視形状よりも小さい。そのため、挟持部71の内壁面は中栓7内に挿入される吸液芯材3の外周面を押圧する。吸液芯材3を押し込みながら挟持部71内に挿入すると、図4に示すように、吸液芯材3は縮径する(外周面が括れる)ように変形し、長さ方向の一部分(挟持部71に挟持される部分)においては外周面が挟持部71の内壁面と当接して挟持部71により挟持される。これにより、吸液芯材3は薬剤容器2の口部20に装着され、口部20から容易に抜け出ることなく薬剤容器2に保持される。 The inner diameter l of the sandwiching portion 71 is smaller than the outer diameter L of the liquid absorbing core material 3, that is, the cross-sectional view shape of the inner wall surface is smaller than the cross-sectional view shape of the liquid absorbing core material 3. Therefore, the inner wall surface of the holding portion 71 presses the outer peripheral surface of the liquid absorbing core material 3 inserted into the inner plug 7. When the liquid-absorbent core material 3 is inserted into the holding portion 71 while being pushed in, the liquid-absorbent core material 3 is deformed so as to shrink in diameter (the outer peripheral surface is constricted) as shown in FIG. In the portion sandwiched by the sandwiching portion 71), the outer peripheral surface abuts on the inner wall surface of the sandwiching portion 71 and is sandwiched by the sandwiching portion 71. As a result, the liquid absorbing core material 3 is attached to the mouth portion 20 of the drug container 2 and is held in the drug container 2 without easily coming out of the mouth portion 20.
 テーパー部72は、下方に向かうに内径及び外径が次第に小さくなる。吸液芯材3を中栓7内に挿入する際、テーパー部72により吸液芯材3は次第に縮径するよう変形して挟持部71に到達するので、吸液芯材3を挟持部71内にスムーズに挿入可能である。 The inner and outer diameters of the tapered portion 72 gradually decrease toward the bottom. When the liquid-absorbent core material 3 is inserted into the inner plug 7, the liquid-absorbent core material 3 is gradually deformed by the tapered portion 72 so as to reach the sandwiching portion 71, so that the liquid-absorbing core material 3 is inserted into the sandwiching portion 71. It can be inserted smoothly inside.
 中栓7の素材としては、特に限定されないが、例えば合成樹脂より具体的にはポリエチレンテレフタレートなどを挙げることができる。 The material of the inner plug 7 is not particularly limited, but for example, polyethylene terephthalate or the like can be mentioned more specifically than the synthetic resin.
吸液芯材
 吸液芯材3は、薬剤容器2への挿入前は直線状に延びる棒状の部材であり、特に限定されないが、横断面視形状が円形状の円柱状を呈する。また、吸液芯材3は、特に限定されないが、全長にわたって太さがほぼ変わらず、全長にわたって横断面視が略同一外径Lの円形状を呈する。吸液芯材3は、薬剤容器2内に口部20から挿入されて使用される。吸液芯材3の長さは、下端が薬剤容器2の内底面に到達するとともに上端側の一部分が薬剤容器2の口部20から上方に突出可能な長さとされる。吸液芯材3の下端が薬剤容器2の内底面に到達することにより、薬剤容器2内の薬液の残量が少なくなっても吸液芯材3による薬液の吸い上げが可能である。
Liquid- absorbent core material The liquid-absorbent core material 3 is a rod-shaped member that extends linearly before being inserted into the drug container 2, and is not particularly limited, but exhibits a columnar shape having a circular cross-sectional view. Further, the liquid absorbing core material 3 is not particularly limited, but exhibits a circular shape having substantially the same outer diameter L in cross-sectional view over the entire length and the thickness is substantially the same over the entire length. The liquid absorbing core material 3 is inserted into the drug container 2 from the mouth portion 20 and used. The length of the liquid absorbing core material 3 is such that the lower end reaches the inner bottom surface of the drug container 2 and a part of the upper end side can protrude upward from the mouth portion 20 of the drug container 2. Since the lower end of the liquid-absorbing core material 3 reaches the inner bottom surface of the drug container 2, the drug solution can be sucked up by the liquid-absorbing core material 3 even if the remaining amount of the drug solution in the drug container 2 is low.
 吸液芯材3は、毛細管現象により薬剤容器2内の薬液を吸い上げることができ、かつ、吸い上げた薬液を外部空間に揮散させることができる限り、その素材は特に限定されない。例えばナイロン、ポリエステル(例えばポリエチレンテレフタレート)、ポリプロピレン、ポリエチレン、ポリオキシメチレン、イソパラフィン、セルロース、ラタン、パルプなど、種々の材料を吸液芯材3の素材として挙げることができ、これらの材料は1種単独で用いてもよく、又は2種以上を組み合わせて用いてもよい。また、特に限定されないが、例えば高温下での吸液芯材3の変形を抑制して吸液芯材3の形状を安定に維持するなどを目的として、その他の好適な材料を吸液芯材3の素材としてさらに用いてもよい。 The material of the liquid-absorbing core material 3 is not particularly limited as long as the chemical solution in the drug container 2 can be sucked up by the capillary phenomenon and the sucked-up drug solution can be volatilized in the external space. For example, various materials such as nylon, polyester (for example, polyethylene terephthalate), polypropylene, polyethylene, polyoxymethylene, isoparaffin, cellulose, rattan, and pulp can be mentioned as the material of the liquid absorbing core material 3, and these materials are one kind. It may be used alone or in combination of two or more. Further, although not particularly limited, for the purpose of suppressing deformation of the liquid absorbing core material 3 at high temperatures and maintaining a stable shape of the liquid absorbing core material 3, other suitable materials may be used as the liquid absorbing core material. It may be further used as the material of 3.
 吸液芯材3は、好ましくは薬液を良好に吸い上げるために、例えば繊維状材料を溶着又は接着させて棒状に成形したもの、繊維状材料を編んで棒状にしたもの、繊維状材料を用いた不織布を棒状にしたもの、スポンジを棒状に成形したものを使用することができる。 As the liquid-absorbing core material 3, for example, in order to satisfactorily suck up the chemical solution, for example, a material obtained by welding or adhering a fibrous material to form a rod, a material obtained by knitting a fibrous material into a rod, or a fibrous material was used. A non-woven fabric in the shape of a rod or a sponge in the shape of a rod can be used.
 吸液芯材3は、特に限定されないが、例えば外周面の強度を向上させるなどの処理が施されていてもよい。これにより、薬剤容器2内に挿入するなどの際にユーザが吸液芯材3を手で持って外周面が幾度となく擦られたとしても、吸液芯材3に毛羽立ちができるなど、吸液芯材3がダメージを受けることを抑制できる。 The liquid absorbing core material 3 is not particularly limited, but may be treated, for example, to improve the strength of the outer peripheral surface. As a result, even if the user holds the liquid absorbing core material 3 by hand and the outer peripheral surface is rubbed many times when the liquid absorbing core material 3 is inserted into the drug container 2, the liquid absorbing core material 3 can be fluffed and absorbed. It is possible to prevent the liquid core material 3 from being damaged.
 図4に示すように、吸液芯材3は、薬剤容器2内に挿入した際に、吸液芯材3の外径Lが口部20の挟持部71の内径lよりも大きいと、長さ方向の一部分が挟持部71に挟持されて、挟持部71に挟持された部分が縮径するよう変形する。このように、薬剤容器2内に挿入された吸液芯材3が口部20の挟持部71により締め付けられることで、吸液芯材3の毛細管が細くなり、毛細管現象による薬液の吸い上げ機能が促進される。これにより、吸液芯材3による薬液の吸い上げ量が増加し、例えば吸液芯材3の外周面の強度を向上させる処理などを行うことにより吸液芯材3が外周面から薬液を吸い上げにくい仕様とされた場合であっても、吸液芯材3は下端面から十分な量の薬液を吸い上げて薬剤成分を外部空間に良好に揮散可能である。 As shown in FIG. 4, when the liquid absorbing core material 3 is inserted into the drug container 2, the outer diameter L of the liquid absorbing core material 3 is longer than the inner diameter l of the holding portion 71 of the mouth portion 20. A part in the wedge direction is sandwiched by the sandwiching portion 71, and the portion sandwiched by the sandwiching portion 71 is deformed so as to have a reduced diameter. In this way, the liquid-absorbing core material 3 inserted into the drug container 2 is tightened by the holding portion 71 of the mouth portion 20, so that the capillaries of the liquid-absorbing core material 3 become thin, and the function of sucking up the chemical liquid by the capillary phenomenon is performed. Be promoted. As a result, the amount of the chemical liquid sucked up by the liquid absorbing core material 3 increases, and it is difficult for the liquid absorbing core material 3 to suck up the chemical liquid from the outer peripheral surface by performing a treatment for improving the strength of the outer peripheral surface of the liquid absorbing core material 3, for example. Even when the specifications are specified, the liquid absorbing core material 3 can suck up a sufficient amount of the chemical liquid from the lower end surface and satisfactorily volatilize the chemical components into the external space.
 吸液芯材3の外径Lは、特に限定されないが、上述の薬剤容器2の口部20による締め付けによって毛細管現象による薬液の吸い上げ機能を効果的に促進させるとの観点から、挟持部71の内径lの1.05倍以上であることが好ましく、1.1倍以上であることがより好ましい。また、吸液芯材3の変形のしやすさにもよるが、吸液芯材3について挟持部71を無理なく通過させるとの観点から、吸液芯材3の外径Lは、挟持部71の内径lの1.5倍以下であることが好ましく、1.2倍以下であることがより好ましい。 The outer diameter L of the liquid absorbing core material 3 is not particularly limited, but from the viewpoint of effectively promoting the function of sucking up the chemical liquid due to the capillary phenomenon by tightening by the mouth portion 20 of the above-mentioned drug container 2, the holding portion 71 The inner diameter l is preferably 1.05 times or more, and more preferably 1.1 times or more. Further, although it depends on the ease of deformation of the liquid absorbing core material 3, the outer diameter L of the liquid absorbing core material 3 is the holding portion from the viewpoint of allowing the liquid absorbing core material 3 to pass through the holding portion 71 without difficulty. The inner diameter l of 71 is preferably 1.5 times or less, and more preferably 1.2 times or less.
 吸液芯材3において挟持部71により挟持される部分の長さ、つまりは挟持部71の高さは、特に限定されないが、上述の薬剤容器2の口部20による締め付けによって毛細管現象による薬液の吸い上げ機能を効果的に促進させるとの観点から、吸液芯材3の全長の1/5以上4/5以下であることが好ましく、2/5以上3/5以下であることがより好ましい。 The length of the portion of the liquid absorbing core material 3 that is sandwiched by the sandwiching portion 71, that is, the height of the sandwiching portion 71 is not particularly limited, but the drug solution due to the capillary phenomenon due to the tightening by the mouth portion 20 of the drug container 2 described above is not particularly limited. From the viewpoint of effectively promoting the suction function, it is preferably 1/5 or more and 4/5 or less of the total length of the liquid absorbing core material 3, and more preferably 2/5 or more and 3/5 or less.
キャップ
 キャップ4は、薬剤揮散器1の非使用時に、薬剤容器2の上方に露出した吸液芯材3の一部分を密封するためのものである。キャップ4は、特に限定されないが、合成樹脂製であり、図2及び図6に示すように、上端が閉鎖されかつ下端が開口した円筒状の覆い部40と、覆い部40よりも外径が大きくかつ中央に覆い部40が上方に延びるように連なる円筒状の取付部41とを含む。
The cap cap 4 is for sealing a part of the liquid absorbing core material 3 exposed above the drug container 2 when the drug volatilizer 1 is not used. The cap 4 is not particularly limited, but is made of synthetic resin, and as shown in FIGS. 2 and 6, the cap 4 has a cylindrical covering portion 40 having a closed upper end and an open lower end, and an outer diameter larger than that of the covering portion 40. It includes a large and centrally connected cylindrical mounting portion 41 such that the covering portion 40 extends upward.
 覆い部40は、内部に吸液芯材3の薬剤容器2の上方に露出した部分を収容できる内径及び高さを有する。取付部41は、薬剤容器2の口部20を内側に嵌め込むことができる内径を有する。取付部41の内周面には、薬剤容器2の口部20の外周面、具体的には筒体61の外周面に設けられた雄ねじ68と螺合する雌ねじ42が設けられる。 The covering portion 40 has an inner diameter and a height capable of accommodating a portion of the liquid absorbing core material 3 exposed above the drug container 2 inside. The mounting portion 41 has an inner diameter that allows the mouth portion 20 of the drug container 2 to be fitted inward. On the inner peripheral surface of the mounting portion 41, a female screw 42 screwed with a male screw 68 provided on the outer peripheral surface of the mouth portion 20 of the drug container 2, specifically, the outer peripheral surface of the tubular body 61 is provided.
カバー
 カバー5は、薬剤揮散器1の使用時に薬剤揮散器1の美感を向上させるためのものである。カバー5は、特に限定されないが、合成樹脂製であり、図1、図2及び図7に示すように、平面視矩形状の天面部50と、天面部50の外周縁から垂下する周面部51とを含む。
The cover cover 5 is for improving the aesthetic appearance of the drug volatilizer 1 when the drug volatilizer 1 is used. The cover 5 is not particularly limited, but is made of synthetic resin, and as shown in FIGS. 1, 2, and 7, a top surface portion 50 having a rectangular shape in a plan view and a peripheral surface portion 51 hanging from the outer peripheral edge of the top surface portion 50. And include.
 周面部51は、薬剤容器2の肩部64を内側に嵌め込むことが可能であり、肩部64は周面部51内に嵌合する。周面部51の内面の下端には内側に突き出る複数の係合突起52が周方向に間隔をあけて設けられる。複数の係合突起52は、薬剤容器2の段差部66の凹部67に係合する。カバー5の天面部50や周面部51には、吸液芯材3により吸い上げられて揮散する薬液の薬剤成分を外部空間に放出するための複数の揮散孔53が形成される。 The peripheral surface portion 51 can fit the shoulder portion 64 of the drug container 2 inward, and the shoulder portion 64 fits inside the peripheral surface portion 51. At the lower end of the inner surface of the peripheral surface portion 51, a plurality of engaging protrusions 52 protruding inward are provided at intervals in the circumferential direction. The plurality of engaging protrusions 52 engage with the recesses 67 of the stepped portion 66 of the drug container 2. On the top surface portion 50 and the peripheral surface portion 51 of the cover 5, a plurality of volatilization holes 53 for discharging the drug components of the drug solution that are sucked up and volatilized by the liquid absorbing core material 3 into the external space are formed.
薬剤揮散器の使用方法
 次に、上述した本実施形態の薬剤揮散器1の使用方法について説明する。まず、使用開始前においては、薬剤容器2の口部20にはキャップ4が装着されており、吸液芯材3は密封されている。そのため、使用開始時には、薬剤容器2の底部62を下にキャップ4を上に向けた状態でキャップ4を薬剤容器2の口部20から取り外す。これにより、吸液芯材3が露出し、薬剤容器2内の薬液は吸液芯材3により吸い上げられ、薬液の薬剤成分が外部空間に連続的に揮散する。その結果、薬剤揮散器1の設置された空間を快適空間にすることができる。薬剤揮散器1の使用中は、必要に応じて薬剤容器2にカバー5を装着することができる。
Method of using the drug volatilizer Next, the method of using the drug volatilizer 1 of the present embodiment described above will be described. First, before the start of use, the cap 4 is attached to the mouth 20 of the drug container 2, and the liquid absorbing core material 3 is sealed. Therefore, at the start of use, the cap 4 is removed from the mouth 20 of the drug container 2 with the bottom 62 of the drug container 2 facing down and the cap 4 facing up. As a result, the liquid absorbing core material 3 is exposed, the chemical liquid in the drug container 2 is sucked up by the liquid absorbing core material 3, and the chemical components of the chemical liquid are continuously volatilized in the external space. As a result, the space in which the drug volatilizer 1 is installed can be made a comfortable space. While the drug volatilizer 1 is in use, the cover 5 can be attached to the drug container 2 as needed.
薬剤揮散器による作用・効果
 上述した本実施形態の薬剤揮散器1は、底部62の内底面に液溜まり部65が設けられている。そのため、薬剤容器2内の薬液の残量が減少して液面が底部62の内底面付近となった場合に、薬液は表面張力により液溜まり部65の方に向かって引っ張られて液溜まり部65に集まる。液溜まり部65の直上には吸液芯材3の下端部が位置するので、液溜まり部65に集まった薬液を吸液芯材3の下端部により吸い上げることができる。このように、本実施形態の薬剤揮散器1は、液溜まり部65の存在により、薬剤容器2内の薬液の残量が減少しても、吸液芯材3により良好に薬液を吸い上げて外部空間に薬剤成分を揮散させることできる。
Actions and effects of the drug volatilizer The drug volatilizer 1 of the present embodiment described above is provided with a liquid pool portion 65 on the inner bottom surface of the bottom portion 62. Therefore, when the remaining amount of the chemical solution in the drug container 2 decreases and the liquid level becomes near the inner bottom surface of the bottom portion 62, the chemical solution is pulled toward the liquid pool portion 65 by the surface tension and the liquid pool portion Gather at 65. Since the lower end portion of the liquid absorbing core material 3 is located directly above the liquid collecting portion 65, the chemical liquid collected in the liquid collecting portion 65 can be sucked up by the lower end portion of the liquid absorbing core material 3. As described above, in the drug volatilizer 1 of the present embodiment, even if the remaining amount of the drug solution in the drug container 2 decreases due to the presence of the liquid pool portion 65, the liquid absorbing core material 3 satisfactorily sucks up the drug solution to the outside. The drug component can be volatilized in the space.
 また、本実施形態の薬剤揮散器1によれば、液溜まり部65は、外径が吸液芯材3の少なくとも下端の外径よりも小さく、吸液芯材3により上方から覆われる。そのため、液溜まり部65上には全体的に吸液芯材3の下端面が面する。例えば吸液芯材3について外周面の強度を向上させる処理を施すなど、吸液芯材3の仕様によっては吸液芯材3の外周面から薬液を吸い上げ難くなるケースがあるが、液溜まり部65が吸液芯材3により上方から覆われることにより、液溜まり部65に集まった薬液を吸液芯材3の下端面から効率よく吸い上げることができる。よって、吸液芯材3が外周面から薬液を吸い上げにくい仕様であっても、吸液芯材3により薬剤容器2内の薬液を可能な限り全て吸い上げて薬液を最後まで使い切ることができる。 Further, according to the chemical volatilizer 1 of the present embodiment, the liquid pool portion 65 has an outer diameter smaller than the outer diameter of at least the lower end of the liquid absorbing core material 3, and is covered from above by the liquid absorbing core material 3. Therefore, the lower end surface of the liquid absorbing core material 3 faces the liquid collecting portion 65 as a whole. For example, depending on the specifications of the liquid absorbing core material 3, it may be difficult to suck up the chemical liquid from the outer peripheral surface of the liquid absorbing core material 3, such as processing to improve the strength of the outer peripheral surface of the liquid absorbing core material 3. Since the 65 is covered with the liquid absorbing core material 3 from above, the chemical liquid collected in the liquid collecting portion 65 can be efficiently sucked up from the lower end surface of the liquid absorbing core material 3. Therefore, even if the liquid absorbing core material 3 has a specification that it is difficult to suck up the chemical liquid from the outer peripheral surface, the liquid absorbing core material 3 can suck up all the chemical liquid in the drug container 2 as much as possible and use up the chemical liquid to the end.
薬剤揮散器の変形例
 以上、本発明の実施形態について説明したが、本発明は上述した実施形態に限定されるものではなく、本発明の趣旨を逸脱しない限りにおいて種々の変更が可能である。
Modifications of the Chemical Volatilizer Although the embodiments of the present invention have been described above, the present invention is not limited to the above-described embodiments, and various modifications can be made without departing from the spirit of the present invention.
 上述した実施形態では、吸液芯材3の横断面視形状が円形状であるとともに、薬剤容器2の口部20の挟持部71における内壁面の横断面視形状が円形状であり、かつ、吸液芯材3の外径が挟持部71の内径よりも大きいため、吸液芯材3は挟持部71において外周面の全周にわたって挟持部71の内壁面に当接する。ただし、吸液芯材3の外周面の全周を挟持部71の内壁面に当接させる必要はなく、一変形例として、吸液芯材3の外周面に長さ方向に延びる溝状のスリットを形成し、吸液芯材3を当該スリットがある部分において挟持部71の内壁面に当接させずに、薬剤容器2の収容空間21と外部空間を連通させて薬剤容器2の内外を空気が流通可能としてもよい。 In the above-described embodiment, the cross-sectional view of the liquid absorbing core material 3 is circular, and the cross-sectional view of the inner wall surface of the holding portion 71 of the mouth portion 20 of the drug container 2 is circular. Since the outer diameter of the liquid absorbing core material 3 is larger than the inner diameter of the holding portion 71, the liquid absorbing core material 3 abuts on the inner wall surface of the holding portion 71 over the entire circumference of the outer peripheral surface of the holding portion 71. However, it is not necessary to bring the entire circumference of the outer peripheral surface of the liquid absorbing core material 3 into contact with the inner wall surface of the sandwiching portion 71. A slit is formed, and the inside and outside of the medicine container 2 are communicated with the storage space 21 of the medicine container 2 and the outside space without contacting the liquid absorbing core material 3 with the inner wall surface of the holding portion 71 at the portion where the slit is located. Air may be able to flow.
 また、上述した実施形態では、吸液芯材3の横断面視形状が円形状であるが、他の変形例として、吸液芯材3の横断面視形状を例えば三角形状や四角形状などの多角形状としてもよいし、楕円形状などのその他の様々な形状としてもよい。この変形例では、図8に示すように、吸液芯材3の横断面視形状が内接する円S1の直径を挟持部71の内径よりも大きくすることで、吸液芯材3の横断面視形状を挟持部71の内壁面の横断面視形状に重ね合わせた際に吸液芯材3の横断面視形状の一部分が挟持部71の内壁面の横断面視形状の外側にはみ出る。よって、挟持部71の内壁面の横断面視形状を吸液芯材3の挟持部71に挟持される部分の横断面視形状よりも小さくすることができ、これにより、吸液芯材3は、挟持部71に挟持される部分において、その外周面の一部分が挟持部71の内壁面により押圧される。その結果、薬剤容器2内に挿入された吸液芯材3は口部20の挟持部71により締め付けられるため、吸液芯材3の毛細管現象による薬液の吸い上げ機能を促進することができる。 Further, in the above-described embodiment, the cross-sectional view of the liquid-absorbent core material 3 is circular, but as another modification, the cross-sectional view of the liquid-absorbent core material 3 is, for example, triangular or square. It may be a polygonal shape or various other shapes such as an elliptical shape. In this modification, as shown in FIG. 8, the cross-sectional view of the liquid-absorbing core material 3 is cross-sectionally formed by making the diameter of the inscribed circle S1 larger than the inner diameter of the sandwiching portion 71. When the visual shape is superimposed on the cross-sectional view shape of the inner wall surface of the sandwiching portion 71, a part of the cross-sectional view shape of the liquid absorbing core material 3 protrudes to the outside of the cross-sectional view shape of the inner wall surface of the sandwiching portion 71. Therefore, the cross-sectional view shape of the inner wall surface of the holding portion 71 can be made smaller than the cross-sectional view shape of the portion sandwiched by the holding portion 71 of the liquid absorbing core material 3, whereby the liquid absorbing core material 3 can be made smaller. In the portion sandwiched by the sandwiching portion 71, a part of the outer peripheral surface thereof is pressed by the inner wall surface of the sandwiching portion 71. As a result, since the liquid-absorbing core material 3 inserted into the drug container 2 is tightened by the holding portion 71 of the mouth portion 20, it is possible to promote the function of sucking up the drug solution due to the capillary phenomenon of the liquid-absorbing core material 3.
 また、上述した実施形態では、薬剤容器2の口部20の挟持部71における内壁面の横断面視形状が円形状であるが、他の変形例として、挟持部71の内壁面の横断面視形状を例えば三角形状や四角形状などの多角形状としてもよいし、楕円形状などのその他の様々な形状としてもよい。この変形例では、図9に示すように、挟持部71の内壁面の横断面視形状に内接する円S2の直径よりも吸液芯材3の外径を大きくすることで、吸液芯材3の横断面視形状を挟持部71の内壁面の横断面視形状に重ね合わせた際に吸液芯材3の横断面視形状の一部分が挟持部71の内壁面の横断面視形状の外側にはみ出る。よって、挟持部71の内壁面の横断面視形状を吸液芯材3の挟持部71に挟持される部分の横断面視形状よりも小さくすることができ、これにより、吸液芯材3は、挟持部71に挟持される部分において、その外周面の一部分が挟持部71の内壁面により押圧される。その結果、薬剤容器2内に挿入された吸液芯材3は口部20の挟持部71により締め付けられるため、吸液芯材3の毛細管現象による薬液の吸い上げ機能を促進することができる。 Further, in the above-described embodiment, the cross-sectional view of the inner wall surface of the holding portion 71 of the mouth portion 20 of the drug container 2 is circular, but as another modification, the cross-sectional view of the inner wall surface of the holding portion 71 is seen. The shape may be a polygonal shape such as a triangle shape or a quadrangular shape, or may be various other shapes such as an elliptical shape. In this modification, as shown in FIG. 9, the outer diameter of the liquid absorbing core material 3 is made larger than the diameter of the circle S2 inscribed in the cross-sectional view shape of the inner wall surface of the holding portion 71, whereby the liquid absorbing core material is made larger. When the cross-sectional view shape of 3 is superimposed on the cross-sectional view shape of the inner wall surface of the holding portion 71, a part of the cross-sectional view shape of the liquid absorbing core material 3 is outside the cross-sectional view shape of the inner wall surface of the holding portion 71. It sticks out. Therefore, the cross-sectional view shape of the inner wall surface of the holding portion 71 can be made smaller than the cross-sectional view shape of the portion sandwiched by the holding portion 71 of the liquid absorbing core material 3, whereby the liquid absorbing core material 3 can be made smaller. In the portion sandwiched by the sandwiching portion 71, a part of the outer peripheral surface thereof is pressed by the inner wall surface of the sandwiching portion 71. As a result, since the liquid-absorbing core material 3 inserted into the drug container 2 is tightened by the holding portion 71 of the mouth portion 20, it is possible to promote the function of sucking up the drug solution due to the capillary phenomenon of the liquid-absorbing core material 3.
 なお、吸液芯材3の横断面視形状を円形状以外の形状とし、かつ、挟持部71の内壁面の横断面視形状を円形状以外の形状としてもよい。この変形例においても、図示は省略するが、吸液芯材3の横断面視形状を挟持部71の内壁面の横断面視形状に重ね合わせた際に吸液芯材3の横断面視形状の一部分が挟持部71の内壁面の横断面視形状の外側にはみ出るように、両者の横断面視形状を設計することで、挟持部71の内壁面の横断面視形状を吸液芯材3の挟持部71に挟持される部分の横断面視形状よりも小さくすることができる。 The cross-sectional view shape of the liquid absorbing core material 3 may be a shape other than the circular shape, and the cross-sectional view shape of the inner wall surface of the holding portion 71 may be a shape other than the circular shape. Also in this modification, although not shown, the cross-sectional view shape of the liquid-absorbent core material 3 when the cross-sectional view shape of the liquid-absorbent core material 3 is superimposed on the cross-sectional view shape of the inner wall surface of the holding portion 71. By designing the cross-sectional view shape of both so that a part of the above is projected to the outside of the cross-sectional view shape of the inner wall surface of the holding portion 71, the cross-sectional view shape of the inner wall surface of the holding portion 71 can be changed to the liquid absorbing core material 3. It can be made smaller than the cross-sectional view shape of the portion sandwiched by the sandwiching portion 71.
 また、上述した実施形態では、吸液芯材3は全長にわたって横断面視が略同一外径の円形状を呈するが、他の変形例として、少なくとも挟持部71により挟持される部分について、横断面視形状を挟持部71の内壁面の横断面視形状よりも大きくすればよい。なお、両者の横断面視形状が円形状である場合には、吸液芯材3の挟持部71に挟持される部分の外径を挟持部71の内径よりも大きくし、好ましくは1.05倍以上とし、より好ましくは1.1倍以上とする。 Further, in the above-described embodiment, the liquid absorbing core material 3 exhibits a circular shape having substantially the same outer diameter in cross-sectional view over the entire length, but as another modification, at least a portion sandwiched by the sandwiching portion 71 has a cross-sectional cross section. The visual shape may be larger than the cross-sectional visual shape of the inner wall surface of the sandwiching portion 71. When the cross-sectional view of both is circular, the outer diameter of the portion sandwiched by the sandwiching portion 71 of the liquid absorbing core material 3 is made larger than the inner diameter of the sandwiching portion 71, preferably 1.05. It is doubled or more, more preferably 1.1 times or more.
 また、上述した実施形態では、薬剤容器2の口部20、具体的には中栓7は、挟持部71と嵌合部70とで横断面視形状の大きさ(内径)が異なるが、他の変形例として、高さ方向の全部において挟持部71の横断面視形状と同じ大きさ(内径)としてもよい。 Further, in the above-described embodiment, the mouth portion 20 of the drug container 2, specifically, the inner plug 7, has a different size (inner diameter) in cross-sectional view between the holding portion 71 and the fitting portion 70, but other As a modification of the above, the same size (inner diameter) as the cross-sectional view shape of the sandwiching portion 71 may be used in all directions in the height direction.
 また、上述した実施形態では、薬剤容器2は容器本体6と中栓7を含み、口部20は容器本体6の筒体61と中栓7で構成されるが、他の変形例として、口部20を容器本体6の筒体61のみで構成してもよい。この変形例では、容器本体6の筒体61が中栓7の挟持部71と同じ構造の挟持部を含むように形成される。 Further, in the above-described embodiment, the drug container 2 includes the container body 6 and the inner plug 7, and the mouth portion 20 is composed of the tubular body 61 and the inner plug 7 of the container body 6, but as another modification, the mouth The portion 20 may be composed of only the tubular body 61 of the container body 6. In this modification, the tubular body 61 of the container body 6 is formed so as to include the holding portion having the same structure as the holding portion 71 of the inner plug 7.
 また、上述した実施形態では、薬剤容器2の底部62の内底面の中央に液溜まり部65が位置するが、他の変形例として、吸液芯材3により上方から覆われる範囲内であれば、薬剤容器2の内底面の中央から位置ずれしていてもよい。 Further, in the above-described embodiment, the liquid pool portion 65 is located at the center of the inner bottom surface of the bottom portion 62 of the drug container 2, but as another modification, if it is within the range covered by the liquid absorbing core material 3 from above. , The position may be displaced from the center of the inner bottom surface of the drug container 2.
 また、上述した実施形態では、薬剤容器2の筒体61は、底部62の中央の真上に位置するが、他の変形例として、底部62の中央の真上から位置ずれしていてもよく、それに応じて液溜まり部65は、筒体61から薬剤容器2内に挿入される吸液芯材3により上方から覆われる範囲内であれば、薬剤容器2の底部62の内底面のどこに位置していてもよい。 Further, in the above-described embodiment, the tubular body 61 of the drug container 2 is located directly above the center of the bottom portion 62, but as another modification, the tubular body 61 may be displaced from directly above the center of the bottom portion 62. Accordingly, the liquid pool portion 65 is located on the inner bottom surface of the bottom portion 62 of the drug container 2 as long as it is within the range covered from above by the liquid absorbing core material 3 inserted into the drug container 2 from the tubular body 61. You may be doing it.
 また、上述した実施形態では、吸液芯材3は薬剤容器2内で真っ直ぐ上下方向に起立するように薬剤容器2内に挿入されるが、他の変形例として、吸液芯材3は薬剤容器2内で斜めを向くように薬剤容器2内に挿入されてもよく、それに応じて液溜まり部65は、筒体61から薬剤容器2内に挿入される吸液芯材3により上方から覆われる範囲内であれば、薬剤容器2の底部62の内底面のどこに位置していてもよい。 Further, in the above-described embodiment, the liquid-absorbent core material 3 is inserted into the drug container 2 so as to stand upright in the drug container 2 in the vertical direction, but as another modification, the liquid-absorbent core material 3 is a drug. It may be inserted into the drug container 2 so as to face diagonally in the container 2, and the liquid pool portion 65 is covered from above by the liquid absorbing core material 3 inserted into the drug container 2 from the tubular body 61 accordingly. It may be located anywhere on the inner bottom surface of the bottom portion 62 of the drug container 2 as long as it is within the specified range.
 1  薬剤揮散器
 2  薬剤容器
 3  吸液芯材
 20 薬剤容器の口部
 65 液溜まり部
 71 挟持部
1 Drug volatilizer 2 Drug container 3 Liquid absorbing core 20 The mouth of the drug container 65 Liquid pool 71 Holding

Claims (4)

  1.  液状の薬剤を収容する薬剤容器と、
     下端が薬剤容器の内底面に到達しかつ上端側の一部分が前記薬剤容器から上方に突き出るように前記薬剤容器内に挿入される吸液芯材であって、前記液状の薬剤を吸い上げる吸液芯材と、
    を備え、
     前記薬剤容器の内底面には前記吸液芯材の下端が到達する位置に凹状にへこむ液溜まり部が設けられる、ことを特徴とする薬剤揮散器。
    A drug container that holds liquid drugs and
    A liquid absorbing core material that is inserted into the drug container so that the lower end reaches the inner bottom surface of the drug container and a part of the upper end side protrudes upward from the drug container. With wood,
    Equipped with
    A drug volatilizer characterized in that a liquid pool portion having a concave shape is provided on the inner bottom surface of the drug container at a position where the lower end of the liquid absorbing core material reaches.
  2.  前記液溜まり部は、前記吸液芯材により上方から覆われる大きさをなす、ことを特徴とする請求項1に記載の薬剤揮散器。 The drug volatilizer according to claim 1, wherein the liquid pool portion has a size of being covered from above by the liquid absorbing core material.
  3.  前記吸液芯材の横断面視形状が円形状であり、
     前記液溜まり部の平面視形状が円形状であり、
     前記液溜まり部の外径が前記吸液芯材の下端における内径よりも小さい、ことを特徴とする請求項2に記載の薬剤揮散器。
    The cross-sectional view of the liquid absorbing core material is circular.
    The plan view shape of the liquid pool is circular.
    The drug volatilizer according to claim 2, wherein the outer diameter of the liquid pool portion is smaller than the inner diameter at the lower end of the liquid absorbing core material.
  4.  前記液溜まり部が前記薬剤容器の内底面の中央に位置する、ことを特徴とする請求項1~3のいずれかに記載の薬剤揮散器。 The drug volatilizer according to any one of claims 1 to 3, wherein the liquid pool portion is located at the center of the inner bottom surface of the drug container.
PCT/JP2021/043708 2020-12-08 2021-11-29 Chemical agent volatizer WO2022124124A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020203150A JP2022090700A (en) 2020-12-08 2020-12-08 Drug volatilization receptacle
JP2020-203150 2020-12-08

Publications (1)

Publication Number Publication Date
WO2022124124A1 true WO2022124124A1 (en) 2022-06-16

Family

ID=81973913

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/043708 WO2022124124A1 (en) 2020-12-08 2021-11-29 Chemical agent volatizer

Country Status (3)

Country Link
JP (1) JP2022090700A (en)
TW (1) TW202222654A (en)
WO (1) WO2022124124A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008538939A (en) * 2005-04-28 2008-11-13 ジボダン エス エー Volatile liquid sprayer
JP2014125211A (en) * 2012-12-25 2014-07-07 Kobayashi Pharmaceutical Co Ltd Vaporizer
JP2016182203A (en) * 2015-03-25 2016-10-20 小林製薬株式会社 Chemical volatilizer for cabin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008538939A (en) * 2005-04-28 2008-11-13 ジボダン エス エー Volatile liquid sprayer
JP2014125211A (en) * 2012-12-25 2014-07-07 Kobayashi Pharmaceutical Co Ltd Vaporizer
JP2016182203A (en) * 2015-03-25 2016-10-20 小林製薬株式会社 Chemical volatilizer for cabin

Also Published As

Publication number Publication date
TW202222654A (en) 2022-06-16
JP2022090700A (en) 2022-06-20

Similar Documents

Publication Publication Date Title
US5875968A (en) Liquid air freshener dispenser device with nonporous capillary wicking function
US5749520A (en) Liquid air freshener dispenser device with capillary wicking means
US5749519A (en) Liquid air freshener dispenser device with nonporous wicking means
JP6513032B2 (en) Disinfection cap for disinfecting male luer end of infusion therapy device
US7681806B2 (en) Vapor dispersing device and method
AU2006288971A1 (en) Evaporating device
WO2014208530A1 (en) Chemical agent volatizer
WO2022124124A1 (en) Chemical agent volatizer
WO2022124123A1 (en) Chemical agent volatizer
JP4823683B2 (en) Volatilizer
JP2578242Y2 (en) Volatilization device
JP6279806B1 (en) Portable drug container and manufacturing method thereof
JP2023071266A (en) Liquid container and medicine volatilizer
WO2021261335A1 (en) Chemical solution volatilizer
US20130134234A1 (en) Spill-proof dispersion device for dispersing volatile liquids
JP2016078935A (en) Volatilization instrument
JP3841835B2 (en) Spray container with ethanol for disinfection
JP2541593Y2 (en) Liquid vaporizer
JPS6124273Y2 (en)
WO2023234122A1 (en) Chemical volatilizer and holder
JP5806906B2 (en) Volatilizer
JP4092075B2 (en) Wall-mountable container containing fragrance
WO2021261336A1 (en) Chemical solution volatilizer
JPS6027537B2 (en) Liquid air freshener dispersion device
JPH0743336U (en) Liquid aroma / deodorant volatilization device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21903228

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21903228

Country of ref document: EP

Kind code of ref document: A1